Abbvie Inc Stock Performance
as on December 20, 2025 at 2:29 am IST
Day's Low
Day's High
$222.35$229.44
2.00%
Downside
1.12%
Upside
52 Week's Low
52 Week's High
$164.39$244.8127.55%
Downside
7.90%
Upside
Abbvie Inc share price movements today
- Previous Close
- $222.82
- Open
- $222.94
- Volume
- 6.4M
- Day's Low - High
- $222.35 - $229.44
- 52 Week Low - High
- $164.39 - $244.81
Abbvie Inc Historical Returns
- 1 Month Return
- -4 %
- 3 Month Return
- + 1.9 %
- 1 Year Return
- + 29.18 %
- 3 Year Return
- + 38.92 %
- 5 Year Return
- + 120.64 %
Abbvie Inc Stock Fundamentals & Key Indicators
Check Abbvie Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$400.9B
EPS (TTM)
10.6414
Dividend Yield
3.10%
Quarterly Earnings Growth YOY
-0.89%
PE Ratio (TTM)
171.83
Industry PE ratio
16.448888888888888
PEG Ratio
0.4059
EBITDA
29.5B
Revenue (TTM)
59.6B
Profit Margin
4.00%
Return On Equity TTM
137.96%
Abbvie Inc Stock Valuation
Track how Abbvie Inc P/E has moved over time to understand its valuation trends.
Abbvie Inc in the last 5 years
Lowest (9.14x)
December 31, 2020
Industry (16.45x)
December 22, 2025
Today (171.83x)
December 22, 2025
Highest (21.55x)
September 30, 2025
Today’s Price to Earnings Ratio: 171.83x
Abbvie Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Abbvie Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $400.9B | 120.64% | 171.83 | 4.00% | |
| BUY | $960.5B | 542.66% | 52.62 | 30.99% | |
| BUY | $497.2B | 35.13% | 19.92 | 27.26% | |
| BUY | $252.5B | 27.29% | 13.37 | 29.63% | |
| BUY | $213.7B | 36.19% | 13.14 | 32.88% |
Stock Returns calculator for Abbvie Inc Stock including INR - Dollar returns
The Abbvie Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Abbvie Inc investment value today
Current value as on today
₹1,34,455
Returns
₹34,455
(+34.45%)
Returns from Abbvie Inc Stock
₹29,223 (+29.22%)
Dollar Returns*
₹5,231 (+5.23%)
Analyst Recommendation on Abbvie Inc Stock
Based on 35 analysts
65.71%
Buy
34.29%
Hold
0.00%
Sell
Based on 35 analysts, 65.71% of analysts recommend a 'BUY' rating for Abbvie Inc. Average target price of $244.68
Abbvie Inc Share Price Target
Get share price movements and forecasts by analysts on Abbvie Inc.
What analysts predicted
7.27%UPSIDE
Target Price
$244.68
Current Price
$226.89
Analyzed by
35 Analysts
Target
$244.68
Abbvie Inc target price $244.68, a slight upside of 7.27% compared to current price of $226.89. According to 35 analysts rating.
Abbvie Inc Stock’s Investor Sentiment and Interest
Investment in Abbvie Inc Shares on INDmoney has dropped by -39.96% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Abbvie Inc Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Abbvie Inc Quarterly Profit & Loss
All numbers in Millions USD
Abbvie Inc Annual Profit & Loss
All numbers in Millions USD
Abbvie Inc Quarterly Cash Flow
All numbers in Millions USD
Abbvie Inc Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Abbvie Inc Stock
Check out the Mutual Funds with significant holdings in Abbvie Inc.
Funds | Holdings | Shares Held |
|---|---|---|
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 3.17326% | 2735 |
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.68303% | 13764 |
Global Institutional Holdings in Abbvie Inc
Abbvie Inc News & Key Events
Today's Timeline - 17 December
Wed, 12:39 PM
-AbbVie is undervalued by 46.7% according to DCF analysis, with a projected intrinsic value of $419.64 per share.
Thu, 03:43 AM
-BofA cuts AbbVie's price target to $233, while HSBC raises it to $265, reflecting mixed analyst views on growth prospects.
Insights on Abbvie Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Abbvie Inc has shown positive revenue growth over the last three quarters. The company's revenue increased from $13.34 billion to $15.77 billion, reflecting an average growth of 7.9% each quarter.
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ABBV has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 1 year, Johnson & Johnson has given 42.8% return, outperforming this stock by 13.6%
NEGATIVE IMPACTProfit Down
Abbvie Inc's net profit has decreased for the last three quarters, dropping from $1.28 billion to $186 million. This represents an average decline of 53.5% each quarter.
- NEGATIVE IMPACT
Price Dip
In the last 1 month, ABBV stock has moved down by -4.0%
About Abbvie Inc
| Organisation | Abbvie Inc |
| Headquarters | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 |
| Industry | Health Technology |
| CEO | Mr. Robert A. Michael CPA |
| E-voting on shares | Click here to vote |
Key Management of Abbvie Inc
Name | Title |
|---|---|
Mr. Perry C. Siatis | Executive VP, General Counsel & Secretary |
Mr. Demetris D. Crum | Executive VP & Chief Human Resources Officer |
Dr. Nicholas J. Donoghoe M.D. | Executive VP and Chief Business & Strategy Officer |
Mr. Scott T. Reents | Executive VP & CFO |
Dr. Azita Saleki-Gerhardt Ph.D. | Executive VP & COO |
Dr. Roopal Thakkar M.D. | Executive VP of Research and Development & Chief Scientific Officer |
Ms. Elizabeth Shea | Senior Vice President of Investor Relations |
Mr. Wulff-Erik von Borcke | Senior VP & President of Oncology |
Mr. Robert A. Michael CPA | CEO & Chairman of the Board |
Mr. Jeffrey Ryan Stewart | Executive VP & Chief Commercial Officer |
FAQs
What is Abbvie Inc share price today?
Abbvie Inc share price today is $226.89 as on at the close of the market. Abbvie Inc share today touched a day high of $229.44 and a low of $222.35.
What is the 52 week high and 52 week low for Abbvie Inc share?
Abbvie Inc share touched a 52 week high of $244.81 on and a 52 week low of $164.39 on . Abbvie Inc stock price today i.e. is closed at $226.89,which is 7.32% down from its 52 week high and 38.02% up from its 52 week low.
What is Abbvie Inc's market capitalisation today?
Abbvie Inc market capitalisation is $0.40T as on .
How to invest in Abbvie Inc Stock (ABBV) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Abbvie Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abbvie Inc Shares that will get you 0.0066 shares as per Abbvie Inc share price of $226.89 per share as on December 20, 2025 at 2:29 am IST.
What is the minimum amount required to buy Abbvie Inc Stock (ABBV) from India?
Indian investors can start investing in Abbvie Inc (ABBV) shares with as little as ₹89.552 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹895.52 in Abbvie Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Abbvie Inc share’s latest price of $226.89 as on December 20, 2025 at 2:29 am IST, you will get 0.0441 shares of Abbvie Inc. Learn more about
fractional shares .
What are the returns that Abbvie Inc has given to Indian investors in the last 5 years?
Abbvie Inc stock has given 120.64% share price returns and 21.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?